Search Results - Peter Ordentlich

Refine Results
  1. 1
    Identification of the Antineoplastic Agent 6-Mercaptopurine as an Activator of the Orphan Nuclear Hormone Receptor Nurr1

    Identification of the Antineoplastic Agent 6-Mercaptopurine as an Activator of the Orphan Nuclear Hormone Receptor Nurr1 by Peter Ordentlich, Yingzhuo Yan, Sihong Zhou, Richard A. Heyman

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression

    Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression by Hung‐Ying Kao, Michael Downes, Peter Ordentlich, Ronald M. Evans

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Identification of a nuclear domain with deacetylase activity

    Identification of a nuclear domain with deacetylase activity by Michael Downes, Peter Ordentlich, Hung‐Ying Kao, Jacqueline G. Alvarez, Ronald M. Evans

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Unique forms of human and mouse nuclear receptor corepressor SMRT

    Unique forms of human and mouse nuclear receptor corepressor SMRT by Peter Ordentlich, Michael Downes, Wen Xie, Anna Genin, Nancy B. Spinner, Ronald M. Evans

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    HDAC Inhibitor SNDX-275 Induces Apoptosis in erbB2-Overexpressing Breast Cancer Cells via Down-regulation of erbB3 Expression

    HDAC Inhibitor SNDX-275 Induces Apoptosis in erbB2-Overexpressing Breast Cancer Cells via Down-regulation of erbB3 Expression by Xiaoping Huang, Li‐Zhi Gao, Shuiliang Wang, Choon‐Kee Lee, Peter Ordentlich, Bolin Liu

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression

    A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression by Jangsoon Lee, Chandra Bartholomeusz, Oula C. Mansour, Juliane Humphries, Gabriel N. Hortobágyi, Peter Ordentlich, Naoto T. Ueno

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

    Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer by Angie M. Torres-Adorno, Jangsoon Lee, Takahiro Kogawa, Peter Ordentlich, Debu Tripathy, Bora Lim, Naoto T. Ueno

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine

    The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine by K. D. Senali Abayratna Wansa, Jonathan M. Harris, Grace W. Yan, Peter Ordentlich, George E.O. Muscat

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Notch Inhibition of E47 Supports the Existence of a Novel Signaling Pathway

    Notch Inhibition of E47 Supports the Existence of a Novel Signaling Pathway by Peter Ordentlich, Arthur J. Lin, Chun-Pyn Shen, Christine M. Blaumueller, Kenji Matsuno, Spyros Artavanis‐Tsakonas, Tom Kadesch

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat

    The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, plac... by Yusuke Tomita, Min-Jung Lee, Sunmin Lee, Saori Tomita, Saranya Chumsri, Scott Cruickshank, Peter Ordentlich, Jane B. Trepel

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A histone deacetylase corepressor complex regulates the Notch signal transduction pathway

    A histone deacetylase corepressor complex regulates the Notch signal transduction pathway by Hung‐Ying Kao, Peter Ordentlich, Naoko Koyano‐Nakagawa, Zhenyu Tang, Michael Downes, Chris Kintner, Ronald M. Evans, Tom Kadesch

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Sharp, an inducible cofactor that integrates nuclear receptor repression and activation

    Sharp, an inducible cofactor that integrates nuclear receptor repression and activation by Yanhong Shi, Michael Downes, Wen Xie, Hung‐Ying Kao, Peter Ordentlich, Chih-Cheng Tsai, Michelle Hon, Ronald M. Evans

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML

    Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML by Bing Z. Carter, Wenjing Tao, Po Yee Mak, Lauren B. Ostermann, Duncan H. Mak, Gerard M. McGeehan, Peter Ordentlich, Michael Andreeff

    Published 2021
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  14. 14
    The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis

    The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis by Yi-Shan Lee, Kian‐Huat Lim, Xingrong Guo, Yoshiharu Kawaguchi, Ya‐sheng Gao, Tomasa Barrientos, Peter Ordentlich, Xiao‐Fan Wang, Christopher M. Counter, Tso‐Pang Yao

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells

    Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells by Åsa Wallén‐Mackenzie, Alexander Mata de Urquiza, Susanna Petersson, Francisco Javier Rodríguez, Stina Friling, Joseph Wagner, Peter Ordentlich, Johan Lengqvist, Richard A. Heyman, Ernest Arenas, Thomas Perlmann

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR

    A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR by Nancy L. Urizar, Amy B. Liverman, D'Nette T. Dodds, Frank Valentin Silva, Peter Ordentlich, Yingzhuo Yan, Frank J. Gonzalez, Richard A. Heyman, David J. Mangelsdorf, David D. Moore

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma

    Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma by Ashley Orillion, Ayumi Hashimoto, Nur P. Damayanti, Li Shen, Remi Adelaiye‐Ogala, Sreevani Arisa, Sreenivasulu Chintala, Peter Ordentlich, Chingai Kao, Bennett D. Elzey, Dmitry I. Gabrilovich, Роберто Пили

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma

    ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma by Connie Lee Batlevi, Yvette L. Kasamon, R. G. Bociek, Peter Lee, Lia Gore, Amanda Copeland, Rikke Sørensen, Peter Ordentlich, Scott Cruickshank, Lori Kunkel, Daniela Buglio, Francisco J. Hernandez‐Ilizaliturri, Ahmed Younes

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy

    Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy by Kristin C. Hicks, Karin M. Knudson, Karin L. Lee, Duane H. Hamilton, James W. Hodge, William D. Figg, Peter Ordentlich, Frank R. Jones, Shahrooz Rabizadeh, Patrick Soon‐Shiong, Jeffrey Schlom, Sofia R. Gameiro

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand

    Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand by Patricia J. Willy, Ian R. Murray, Jing Qian, Brett B. Busch, William C. Stevens, Richard Martin, Raju Mohan, Sihong Zhou, Peter Ordentlich, Ping Wei, Douglas W. Sapp, Robert A. Horlick, Richard A. Heyman, Ira G. Schulman

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: